CyDex Pharmaceuticals Extends Agreement with Hovione
LENEXA, Kan.-(Business Wire)-September 21, 2009 - CyDex Pharmaceuticals, Inc. today announced the extension of its relationship with Hovione SA as the company’s exclusive supplier of Captisol® for an additional five years.
“The extension of our relationship with Hovione through 2019 provides assurance for current and future CyDex strategic partners that they will continue to have uninterrupted access to high-quality Captisol®,” said CyDex President and Chief Executive Officer Theron E. Odlaug. “This arrangement is an important step forward as we develop and commercialize pharmaceuticals and therapies using our differentiated cyclodextrin technology.”
Today’s announcement is in conjunction with Odlaug’s presentation at Hovione’s 50th anniversary commemoration at Hovione’s headquarters in Loures, Portugal. “We are pleased to be extending one of CyDex’s most important business relationships,” he said. “Hovione’s ability to consistently meet the highest standards in pharmaceutical manufacturing is evidenced by their 50 years of business excellence. On behalf of the entire CyDex team, I congratulate our partners at Hovione for achieving this milestone.”
About CyDex Pharmaceuticals, Inc.
CyDex Pharmaceuticals, Inc. is a specialty pharmaceutical company developing products and licensing its Captisol® technology. Captisol is currently incorporated in five FDA approved medications and marketed by three of the company’s licensees: Pfizer, Bristol-Myers Squibb and Prism Pharmaceuticals. In addition the company is supporting drug development efforts with more than 40 other companies worldwide. The company maintains patents in the U.S. and worldwide for its Captisol and cyclodextrin technologies, and a comprehensive FDA drug master file for client use. For additional information on business development opportunities, please contact Richard White at rwhite@cydexpharma.com or 913.685.8850. CyDex is a privately held company located in suburban Kansas City. To learn more about the company, please visit www.cydexpharma.com.
 |
 |
 |
|
||
 |
|
 |
|
||
Search Our News Using Google Search
Can't find what you want? Try using Google:
